Skip Navigation

A Phase II Study of Belinostat and SGI-110 Guadecitabine for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma

Brief Summary

Type:
Sarcomas

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT04340843

Study #:
STUDY00146240

Start Date:
Oct 20, 2020

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04340843

View Complete Trial Details & Eligibility at ClinicalTrials.gov